Stem cell mobilization with G-CSF induces Th-17 differentiation and promotes scleroderma

被引：0
|
作者：
MacDonald, K. P. A. [1 ]
Olver, S. [1 ]
Kuns, R. [1 ]
Varelias, A. [1 ]
Raffelt, N. C. [1 ]
Don, A. L. [1 ]
Markey, K. A. [1 ]
Wilson, Y. [1 ]
Smyth, M. J. [2 ]
Iwakura, Y. [3 ]
Tocker, J. [4 ]
Clouston, A. [5 ]
Hill, G. R. [1 ]
机构：
[1] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
[2] Peter MacCallum Canc Ctr, Brisbane, Qld, Australia
[3] Univ Tokyo, Tokyo, Japan
[4] Amgen Inc, Seattle, WA USA
[5] Envoi Pathol, Brisbane, Qld, Australia
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
    Tan, Carlyn Rose C.
    Pancari, Philip A.
    Ulicny, John
    Martin, Mary Ellen
    Barta, Stefan Klaus
    Kropf, Patricia Lamont
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S136
  • [32] High-dose G-CSF stem cell mobilization after initial stem cell-mobilization failure.
    Jennis, A
    Pecora, A
    Preti, R
    Murphy, L
    Goldberg, S
    Cantwell, S
    BLOOD, 1998, 92 (10) : 271A - 271A
  • [33] G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells
    Luyckx, Ariane
    Schouppe, Elio
    Rutgeerts, Omer
    Lenaerts, Caroline
    Fevery, Sabine
    Devos, Timothy
    Dierickx, Daan
    Waer, Mark
    Van Ginderachter, Jo A.
    Billiau, An D.
    CLINICAL IMMUNOLOGY, 2012, 143 (01) : 83 - 87
  • [34] Cytarabine plus G-CSF is more effective than cyclophosphamide plus G-CSF as a stem cell mobilization regimen in multiple myeloma
    Jelinek, Tomas
    Adamusova, Lucie
    Popkova, Tereza
    Tvrda, Ivana
    Smejkalova, Jana
    Simicek, Michal
    Salounova, Dana
    Kascak, Michal
    Mihalyova, Jana
    Plonkova, Hana
    Duras, Juraj
    Navratil, Milan
    Hajek, Roman
    Koristek, Zdenek
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1107 - 1114
  • [35] Peripheral blood stem cell (PBSC) mobilization in breast cancer patients:: Chemotherapy plus G-CSF versus G-CSF alone
    Varo, MJ
    Azaceta, G
    Mayordomo, JI
    Tres, A
    Olave, T
    Moreno, JA
    Domingo, JM
    Gutiérrez, M
    Palomera, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 74 - 74
  • [36] A randomized study of G-CSF vs the combination of G-CSF/GM-CSF on mobilization of dendritic cells in peripheral stem cell grafts.
    Lonial, S
    Rosenthal, H
    Feinstein, B
    Cherry, J
    Dunzel, M
    Waller, EK
    BLOOD, 2000, 96 (11) : 518A - 518A
  • [37] Peripheral blood stem cell mobilization using sequential G-CSF alone followed by CTX/VP-16/G-CSF
    Akard, LP
    Dugan, MJ
    Greenspan, A
    Hanks, S
    Thompson, JM
    Wiemann, MC
    Jansen, J
    BLOOD, 1996, 88 (10) : 3655 - 3655
  • [38] COMPARISON OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF WITH G-CSF ALONE FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN MM
    Jang, J. E.
    Hyun, S. Y.
    Hwang, D. Y.
    Yoon, S. H.
    Kim, Y. D.
    Kim, S. J.
    Kim, J. S.
    Cheong, J. -W.
    Min, Y. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [39] G-CSF (filgrastim) for mobilization of stem cells in healthy donors
    Singhal, S
    Powles, R
    Cabral, S
    Treleaven, J
    Mehta, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 578 - 578
  • [40] Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF
    Basak, G. W.
    Wiktor-Jedrzejczak, W.
    Apperley, J. F.
    Douglas, K. W.
    Gabriel, I. H.
    Geraldes, C.
    Huebel, K.
    Jaksic, O.
    Koristek, Z.
    Lanza, F.
    Lemoli, R.
    Mikala, G.
    Selleslag, D.
    Worel, N.
    Mohty, M.
    Duarte, R. F.
    BONE MARROW TRANSPLANTATION, 2012, 47 (07) : 1003 - 1005
12345